-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $20

Benzinga·04/10/2025 13:18:43
Listen to the news
JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the price target from $18 to $20.